VA
PAHC icon

Vident Advisory’s Phibro Animal Health PAHC Stock Holding History

Vident Advisory’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$437K Sell
13,904
-3,275
-19% -$138K ﹤0.01% 1434
2026
Q1 		$950K Buy
+17,179
New +$818K 0.01% 901

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vident Advisory's PAHC Position: Q2 2026 in Review

Vident Advisory reduced its Phibro Animal Health (PAHC) stake by 19% in Q2 2026, selling an estimated $138K and leaving 13,904 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Vident Advisory first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $950K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Vident Advisory held 13,904 shares of Phibro Animal Health worth $437K as of Q2 2026.
  • Vident Advisory sold 3,275 Phibro Animal Health shares in Q2 2026, an estimated $138K.
  • Phibro Animal Health made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1434 holding.
  • Vident Advisory first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Vident Advisory's Phibro Animal Health position peaked at $950K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.